PubRank

Matthew P Doogue

Author PubWeight™ 20.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical pharmacokinetics of metformin. Clin Pharmacokinet 2011 2.59
2 The half-lives of plasma free metanephrines. Clin Endocrinol (Oxf) 2012 1.42
3 Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations. Med J Aust 2012 1.36
4 Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia. Ann Clin Biochem 2009 1.17
5 Detecting undiagnosed diabetes using glycated haemoglobin: an automated screening test in hospitalised patients. Med J Aust 2011 0.94
6 Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment. Br J Clin Pharmacol 2011 0.91
7 A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time. Br J Clin Pharmacol 2014 0.89
8 Advances in biochemical screening for phaeochromocytoma using biogenic amines. Clin Biochem Rev 2009 0.87
9 Extreme diabetic lipaemia associated with a novel lipoprotein lipase gene mutation. Clin Chim Acta 2009 0.85
10 BICEPP: an example-based statistical text mining method for predicting the binary characteristics of drugs. BMC Bioinformatics 2011 0.82
11 Assessment of inter-individual variability in predicted phenytoin clearance. Eur J Clin Pharmacol 2009 0.81
12 A dose of paracetamol for the levothyroxine absorption test. Clin Endocrinol (Oxf) 2013 0.80
13 Quantification of infant exposure to celecoxib through breast milk. Br J Clin Pharmacol 2006 0.80
14 Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modeling. Pharmacogenet Genomics 2016 0.80
15 Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions. Eur J Clin Pharmacol 2014 0.79
16 An educational intervention to improve vancomycin prescribing and monitoring. Int J Antimicrob Agents 2013 0.78
17 Predicted metabolic drug clearance with increasing adult age. Br J Clin Pharmacol 2013 0.77
18 Mass or molar? Recommendations for reporting concentrations of therapeutic drugs. Med J Aust 2013 0.76
19 Learning more from the dabigatran concentrations in the RE-LY study. J Am Coll Cardiol 2014 0.75
20 Doctors and the pharmaceutical industry: time for a national policy? Med J Aust 2009 0.75
21 Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother 2004 0.75
22 What changes are needed to the current direction and interpretation of clinical cancer research to meet the needs of the 21st century? Med J Aust 2009 0.75
23 Free and total plasma cortisol measured by immunoassay and mass spectrometry following ACTH₁₋₂₄ stimulation in the assessment of pituitary patients. J Clin Endocrinol Metab 2013 0.75